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Background: The purpose was to identify and assess the existing scientific evidence from epidemiologic, non-
experimental, observational studies of associations between Marfan’s syndrome and oral diseases.
Material and Methods: Electronic literature searches in MEDLINE (OVID), The Cochrane Library, Scopus and 
the Web of Science were conducted to identify all relevant articles. Eligibility was based on inclusion criteria, 
and quality assessments were conducted. The outcome variables were probing depth, gingival margin, clinical at-
tachment level, bleeding on probing, gingival status, periodontal status, tooth mobility, furcation involvement and 
decayed, missing and filled teeth index. After extracting data, meta-analyses were carried out. 
Results: Out of 527 potentially eligible papers, 3 cross-sectional studies were included. No statistically significant 
differences were found in the number of sites with bleeding on probing (OR: 1.26; 95% CI: 0.47 to 3.42; P = 0.65; 
I2: 0%), probing depth (MD: -0.14 mm; 95% CI: -0.24 to 0.53; P = 0.46; I2: 93%), periodontal status (WMD: 0.68 
points; 95% CI: -0.48 to 1.83; P = 0.25; I2: 98%) nor number of decayed, missing and filled teeth index score (MD: 
1.08 points.; 95% CI: -1.27 to 3.42; P = 0.37; I2: 0%).
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Introduction
Marfan’s syndrome (MFS) is a multisystem connective 
tissue disorder, first described more than 100 years ago 
by a Parisian professor of paediatrics, Antoine-Bernard 
Marfan (1). Its incidence is about 1 case per 5,000 indi-
viduals, although this figure may be underestimated (2).
This autosomal heritable disease is mainly attributable 
to a defect in the microfibrillar protein fibrillin-1 (FBN1) 
gene on chromosome 15 (15q21.1). This gene encodes 
FBN1, a matrix glycoprotein that is the main constitu-
ent of the microfibrils of the extracellular matrix (3,4). 
FBN1 monomers bond to form complex extracellular 
macroaggregates, called microfibrils, which form part 
of elastic fibers, and confer important biomechanical 
properties in connecting, anchoring, and maintaining 
tissues and organs (2). In addition, it has been proven 
that FBN1 stimulates the release and activation of TFG 
(a potent inflammation stimulator), fibrosis and it also 
activates certain matrix metalloproteinases (MMPs), 
especially MMP-2 ad MMP-9 (5).
MFS manifestations typically involve the cardiovas-
cular, skeletal, and ocular systems. Cardiac disease is 
a predominant feature of MFS and includes proximal 
ascending aortic dilation, dilation of the proximal main 
pulmonary artery, thickening and prolapse of either or 
both atrioventricular valves, mitral annular calcification 
and, in some rare cases, dilated cardiomyopathy in the 
absence of severe valvular dysfunction (6). These com-
plications are recognized as the major cause of morbid-
ity and mortality in patients with MFS. In fact, aortic 
dissection or rupture account for most of the premature 
mortality among patients with MFS, a risk that increas-
es rapidly during adolescence and results in death in 
up to 50% of undiagnosed and untreated patients with 
MFS by the age of 40. Disproportionate overgrowth of 
the long bones is often the most striking and immedi-
ately evident manifestation. Additional skeletal features 
in MFS include arachnodactyly (overgrowth of the fin-
gers), joint hypermobility, anterior chest deformity and 
thoracolumbar scoliosis. With reference to the ocular 
manifestations, ectopia lentis (dislocation of the ocular 
lens) is the most common condition, affecting around 
60% of patients with this disorder (2).  
The diagnosis of MFS is challenging since many of its 
manifestations are present in other syndromes as well 
as in the general population. Although genetic tests are 
available, the diagnostic criteria of the current Ghent 
Conclusions: Patients diagnosed with Marfan’s syndrome do not seem to have worsened oral health status. Due to the 
high number of patients with Marfan’s syndrome that have prosthetic heart valves, an adequate dental monitoring as 
well as a strict maintenance therapy program should be implemented.
 
Key words: Marfan syndrome, oral health, periodontal diseases, caries.
nosology still require clinical manifestations for final 
diagnosis (7).
In addition to the aforementioned multisystemic fea-
tures, MFS also exhibits characteristic oral manifes-
tations including retrognathia, dolichocephaly, high 
palatal vault, crowded teeth, temporomandibular joint 
disorders and partial anodontia (8,9). Moreover, in the 
presence of biofilm on the tooth surface, metabolic and 
compositional alterations of the periodontal ligament 
and/or the extracellular matrix may all have a substan-
tial and negative impact on periodontal tissues, leading 
to increased susceptibility and trigger an inflammatory 
response that ultimately leads to tissue breakdown (10).
Nonetheless, little is still known about the oral health 
status of patients with MFS. Because these patients are 
cared for by dental professionals, it is essential to report 
on oral health features, particularly due to the aforemen-
tioned potential cardiovascular complications. Hence, 
the prevention of bacteremia caused by advanced tooth 
decay, pulpal infection and/or periodontal diseases 
should be prioritized in dental treatment planning.
Therefore, the aim of the present systematic review was 
to identify and assess the existing scientific evidence 
from epidemiologic, non-experimental and observational 
studies of associations between MFS and oral diseases.
Material and Methods
-Protocol and registration
This paper adheres to the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) 
declaration (11) and is registered in PROSPERO under 
number CRD42018115713.
-Eligibility criteria
The predefined study population (P), exposition (E), 
comparison (C), outcome parameters (O) and study 
type (S) (PECOS factors) for eligibility of the studies 
are summarized in Table 1.
Study populations needed to consist of total or partially 
dentate humans whose oral health status had been clini-
cally assessed (population) in order for them to be in-
cluded in the study. Cases had to be diagnosed accord-
ing to Ghent Nosology for MFS criteria (7) (exposition) 
and a comparison group consisting of healthy individu-
als was included in the study (comparison). The results 
needed to include at least one of the following param-
eters related to oral health status reported at the patient 
level (outcomes):
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Population Total or partially dentate participants
Exposure Marfan’s Syndrome
Control Healthy individuals
Outcome Oral health status
Study type Prospective or retrospective cohort studies
Case–control studies
Cross-sectional studies
Table 1: Issues of interest by study population (P), exposure (E), comparison 
(C), outcome (O) and study type (S) (PECOS factors).
• Probing depth (PD):  The distance from the gingival 
margin to the tip of the periodontal probe assessed at six 
sites per tooth.
• Gingival margin (GM): The distance from the gingival 
margin to the cementoenamel junction (CEJ) assessed 
at six sites per tooth.
• Clinical attachment level (CAL): The probing depth 
plus the distance from the gingival margin to the CEJ 
assessed at six sites per tooth.
• Bleeding on probing (BOP): Presence or absence of 
BOP assessed at six sites per tooth.
• Löe-Silness Gingival Index (GI) (12).
• Periodontal status: Assessed by the Community Peri-
odontal Index Treatment Needed (CPITN) (13), the 
Community Periodontal Index (CPI) (14) or the Peri-
odontal Screening and Recording (PSR) index (15).
• Presence or absence of tooth mobility.
• Presence or absence of furcation involvement.
• Decayed, Missing and Filled Teeth Index (DMF-T) 
(16). 
The inclusion criteria were original, prospective or ret-
rospective non-interventional cohort, case–control, or 
cross-sectional studies exploring the status or evolution 
of periodontal health in humans known to have MFS. 
The review excluded studies with less than ten patients 
in the control and/or exposure group. 
-Search strategy 
An electronic search of the MEDLINE (OVID), The Co-
chrane Library (Wiley), Scopus (Elsevier) and the Web of 
Science (Thomson Reuters) databases up to September 1, 
2018 was conducted in order to identify all relevant hu-
man studies without year or language restrictions. 
For the PubMed library, the following research terms 
were applied: (“marfan’s syndrome”[MeSH Terms] 
OR “marfan syndrome”[MeSH Terms] OR “syndrome, 
marfan”[MeSH Terms] OR “syndrome, marfan’s”[MeSH 
Terms]) AND (((“stomatognathic diseases”[MeSH 
Terms] OR “oral manifestations”[Title/Abstract] OR 
“oral diseases”[Title/Abstract] OR “oral health”[MeSH 
Terms] OR “tooth diseases”[MeSH Terms]) OR 
(“dental caries”[MeSH Terms])) OR (“periodontal 
diseases”[MeSH Terms] OR “periodontitis”[MeSH 
Terms] OR “periodontal conditions”[Title/Abstract] OR 
“gingivitis”[MeSH Terms])). For searching the remain-
ing electronic databases, the key terms used were: ‘mar-
fan syndrome’ AND ‘oral health’ OR ‘tooth diseases’ 
OR ‘caries’ OR ‘periodontitis’ OR ‘gingivitis’ OR ‘peri-
odontal diseases’. 
Additionally, grey literature was searched on Open-
Grey** as well as the US National Institutes of Health†† 
in order to identify additional potential candidates to 
be included. The research was completed by a manual 
screening of the references cited in the selected articles 
and reviews. 
-Selection of studies
Two examiners (C.G. and O.C.F.) independently select-
ed the studies in accordance with the inclusion criteria. 
Consensus resolved any disagreements.  
Initially, duplicates or irrelevant publications (based on 
the title) were excluded, and the abstracts were exam-
ined. Finally, the full texts of all the remaining papers 
were assessed. The studies removed at this stage and the 
reasons for their exclusion were recorded (Fig. 1).
Authors were contacted when necessary for clarifica-
tion of missing information. When multiple reports on 
the same patients were identified, only the most recent 
one was included.
-Data extraction and method of analysis
Two reviewers (C.G. and O.C.F.) independently extracted 
the data using data-extraction tables. Whenever possible, 
the following data were retrieved from the selected pa-
pers: author(s), year of publication, country of origin, 
study design and details of the participants and outcomes. 
-Quality and risk of bias assessment
As part of the data extraction process, two reviewers 
(C.G. and O.C.F.) independently assessed the risk of 
bias of the RCTs included, using a modification of the 
Newcastle-Ottawa Scale (NOS) ‡‡. 
** OpenGrey. Available at: www.opengrey.eu. Ac-
cessed September 1, 2018.
†† National Institutes of Health. ClinicalTrials.gov. 
Available at: www.clinicaltrials.gov. Accessed Septem-
ber 1, 2018.
‡‡ Wells G, Shea B, O’Connell D, et al. The Newcastle-
Ottawa Scale (NOS) for assessing the quality of nonran-
domised studies in meta-analyses. Available at: www.
ohri.ca/programs/clinical_epidemiology/oxford.asp. 
Accessed 5 November, 2018.
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Fig. 1: Flow-chart illustrating the study selection process.
The following items were evaluated: 1) selection of 
study groups, 2) comparability of the study groups, 
and 3) outcome. Each study received a maximum of 
13 points for cohort studies, 10 points for case–control 
studies, and 7 for cross-sectional studies.
Authors were contacted for clarification of missing or 
unclear information when necessary. 
-Statistical analysis
For dichotomous outcomes, odds ratios (OR) with 95% 
confidence intervals (95% CI) were used to estimate the 
effect of an exposition. Parametric and nonparametric 
tests (Pearson χ2, Fisher and Mann-Whitney tests) were 
used to compare the groups. For continuous outcomes, 
mean differences (MD) and standard deviations (SD) 
were used to summarize data for each group. The statis-
tical unit was the patient.
A meta-analysis was only performed when studies re-
ported the same outcome measures. Odds ratios and 
MD were combined for dichotomous and continuous 
data, respectively, using random-effects models. The 
random model was selected because it is more general 
than fixed effects models and we assumed heterogene-
ity between studies a priori. Statistical significance was 
defined as P <.05 for all analyses. 
Statistical heterogeneity was estimated by means of χ2 
(Q value) and I2 analyses. A χ2 P-value of <.10 and an 
I2 value of >50% were interpreted as significant hetero-
geneity (17). 
Had there been a sufficient number of meta-analyzed 
studies (more than 10), publication bias, clinical hetero-
geneity assessment and sensitivity analyses would have 
been performed according to Patsopoulos et al. (18).
The statistical analysis was carried out using Review 
Manager software (Review Manager version 5.3; The 
Cochrane Collaboration, Copenhagen, Denmark).
Results
-Study selection and description
The initial electronic database and gray literature re-
search yielded 248 references. After duplicate removal 
and assessment of both titles and abstracts, a total of 6 
articles were eligible for full-text analysis (Fig. 1). The 
reviewers’ agreement was 100%, with a κ index of 1 
(perfect agreement).
After applying the study criteria, 3 publications were 
excluded because of case report (10), animal research 
(19), and absence of a control group (20), respectively. 
Finally, 3 cross-sectional studies fulfilled the inclusion 
criteria and were selected for qualitative and quantita-
tive synthesis (8,9,21) (Table 2).
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Figure 1 shows a flowchart of the screening process.
-Risk-of-bias assessment
All 3 studies were assessed by the modified and adapted 
NOS. The mean NOS score was 4 (Range: 3 to 5), be-
ing the domain “Selection” the highest ranked and the 
“Outcome” the lowest (Table 3).
-Extraction data
°Qualitative synthesis
The three studies selected comprised 228 patients, 114 
of whom were diagnosed of MFS and the rest served as 
controls (Table 4, 4 continue) (8,9,21).
None of the studies revealed significant differences be-
tween the groups in terms of CAL, GM, BOP, GI, tooth 
mobility, furcation involvement nor DMF-T index score 
(P > 0.05) (Table 4, 4 continue).
Suzuki et al. (21) found higher PD (MD: 0.33 mm; 95% 
CI: 0.26 to 0.40; P < 0.001) as well as CPI scores (MD: 
1.26 points; 95% CI: 1.09 to 1.43; P < 0.001) in patients 
with MFS (Table 4, 4 continue). Additionally, one pa-
per reported worsened gingival conditions among MFS 
participants (MD: 0.93 points; 95% CI: 0.53 to 1.33; P < 
0.001) (Table 4, 4 continue) (9).
°Quantitative synthesis
No statistically significant differences were found in 
periodontal status (MD: 0.68 points; 95% CI: -0.48 to 
1.83; P = 0.25; I2: 98%) (Fig. 2A), PD (MD: -0.14 mm; 
95% CI: -0.24 to 0.53; P = 0.46; I2: 93%) (Fig. 2B), BOP 
(OR: 1.26; 95% CI: 0.47 to 3.42; P = 0.65; I2: 0%) (Fig-
ure 2C) or DMF-T score (MD: 1.08 points.; 95% CI: 
-1.27 to 3.42; P = 0.37; I2: 0%) (Fig. 2D).
Discussion
To our knowledge, the present study, which used rec-
ommended methods for systematic reviews and meta-
analyses, is the first that has quantitatively analyzed the 
relationship between MFS and oral health status.
Three analytical cross-sectional studies involving total 
or partially dentate participants evaluated if patients 
diagnosed with MFS had a higher risk of developing 
oral diseases compared to healthy individuals (8,9,21). 
Meta-analysis of these papers showed MFS groups were 
not associated with significantly worsened BOP rates, 
mean PD, periodontal status or DMT-T score (Figure 2). 
However, these results should be approached with cau-
tion since all four investigations had a potential risk of 
bias. In addition, their internal validity may have been 
compromised because longitudinal designs only allow 
us to establish a true cause and effect relationship. This 
issue could affect the reliability and quality of the stud-
ies. Furthermore, none of the papers included reported 
any sample size calculations. Given the small number of 
participants in all these studies, a type II error (failure 
to reject a false null hypothesis) may have occurred due 
to inadequate statistical power. Another possible limi-
tation of this article is that due to the small number of 
papers available for review an evaluation of publication 
bias (i.e., funnel plot) could not be carried out (18).
Periodontal disease is initiated by microorganisms in 
the subgingival biofilm, and lifestyle risk factors, as 
well as systemic diseases, play a role in modifying the 
disease (22). Although some authors have suggested 
that connective tissue disorders, such as MFS, are re-
lated with a higher prevalence or more severe forms of 
periodontitis (10,21,23,24), others, as well as our results 
(Fig. 2A,B), failed to demonstrate such associations (8). 
A possible explanation for this difference may be at-
tributed to the fact that periodontitis is a complex and 
multifactorial chronic disease (22). In this sense, indi-
vidual risk factors such as smoking, diabetes, poor oral 
hygiene or nutrition may be far more critical than the 
disorder itself. Nevertheless, it seems reasonable that 
patients with MFS should be considered to be a popu-
lation group more susceptible to inflammatory break-
down of periodontal tissues. Therefore, strict mainte-
nance therapy for the prevention of periodontal diseases 
is of utmost importance since it can prevent the onset of 
these afflictions or attenuate their severity.
De Coster et al. (9) revealed a worse gingival index 
in MFS patients when compared to controls (Table 4, 
4 continue). To the contrary, when a more objective 
method such as BOP was used to assess periodontal 
inflammation, no significant differences were found 
between the groups (Fig. 2C). One explanation for this 
may be that other variables could act as confounders. In 
this regard, crowded teeth are usually found in subjects 
with MFS (8,23). Undeniably, maintaining a proper oral 
hygiene can be challenging in these cases. Therefore, 
the higher degree of inflammation in patients with MFS 
may have been the result of the malocclusion rather than 
a true manifestation of the disorder (8).
Dental examination of patients with MFS can reveal the 
presence of local spots of hypoplastic enamel, root de-
formity, abnormal pulp shape and pulpal inclusions (9). 
However, no differences were found between groups in 
terms of DMF-T score (Fig. 2D) according to the results 
of our metanalysis. 
It has been claimed that Marfan patients have a higher 
risk of developing bacterial endocarditis (25). Although 
the present study failed to find significant differences 
between groups, the prevention of bacteremia caused by 
advanced tooth decay, pulpal infection and/or periodon-
tal diseases should be given high priority in dental treat-
ment planning in MFS patients, especially in those who 
wear prosthetic heart valves or other devices for treat-
ing the syndrome’s cardiovascular complications of the 
syndrome. Therefore, an adequate dental monitoring as 
well as a strict maintenance therapy program should be 
implemented.
The goal of a systematic review is not only to qualify 
and synthesize the scientific evidence, but also to map 
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Section
Author (year) Selection Comparability Outcome/Exposure Major limitations
De Coster et al. 
(2002)
** * * Inequitable sample between exposed and controls.
No information on possible overlapping of other 
confounding factors.
Staufenbiel et al. 
(2013)
** ** * No information on sample representativeness.
Inequitable sample between exposed and controls.
Suzuki et al. 
(2015)
** * * No information on sample representativeness.
Inequitable sample between exposed and controls.
No information on possible overlapping of other 
confounding factors.
Table 3: Quality assessment of 3 studies included in the qualitative evaluation according to the modified Newcastle-Ottawa Scale (NOS).
De Coster et al.
(2002)
Staufenbiel et al. (3) 
(2013)
Suzuki et al. (20) 
(2015)
N° of patients (males/females)
   MFS







Age of participants (years)
   MFS (SD) [Range]
   Control (SD) [Range]
26.17 [9 to 53]






   MFS (SD)










1.26 (1.09 to 1.43)
<0.001*§
Gingival index (score)
   MFS (SD)





0.93 (0.53 to 1.33)
<0.001*
Not reported Not reported
Clinical attachment level (mm)
   MFS (SD)






-0.08 (-0.34 to 0.18)
0.546
Not reported
Table 4: Comparison of the selected studies.
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Probing depth (mm)
   MFS (SD)










0.33 (0.26 to 0.40)
<0.001*
Gingival margin (mm)
   MFS (SD)






0.02 (-0.13 to 0.17)
0.795
Not reported
Bleeding on probing 
   MFS (%)










1.86 (0.20 to 17.43)
0.588
Tooth mobility (score)
   MFS (SD)










   MFS (SD)










   MFS (SD)









0.84 (-2.29 to 3.97)
0.605
Not reported
Table 4 continue: Comparison of the selected studies.
†Periodontal Screening and Recording index
§Community Periodontal Index
*Statistically significant (P < 0.05) 
out and categorize the existing literature on a particular 
topic (26). This is undertaken in order to characterize 
the quantity and quality of available information and 
based on this new knowledge to provide recommenda-
tions for future investigations as bias-free as possible 
(27). Accordingly, researchers are encouraged to ex-
amine the effect of MFS as an independent risk factor 
in the development, progression, and severity of oral 
diseases compared to completely healthy subjects in or-
der to validate or refute our findings. Future research 
should therefore be based on longitudinal studies in or-
der to detect developments or changes over a long pe-
riod of time focusing on the characteristics of the target 
population at both the group and the individual level.














































































































































According to the results of our meta-analysis, MFS is 
not associated with worsened oral health status. Never-
theless, since only three analytical cross-sectional stud-
ies were included, longitudinal designs are needed to 
establish a true cause and effect relationship. Moreover, 
due to the high number of MFS patients with prosthetic 
heart valves, an adequate dental monitoring as well as 
a strict maintenance therapy program should be imple-
mented in order to prevent the onset or to attenuate the 
severity of oral diseases.
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